Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice
- PMID: 15707974
- PMCID: PMC7092846
- DOI: 10.1016/j.bbrc.2005.01.048
Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice
Abstract
Vaccination against the SARS-CoV infection is an attractive means to control the spread of viruses in public. In this study, we employed a DNA vaccine technology with the levamisole, our newly discovered chemical adjuvant, to generate Th1 type of response. To avoid the enhancement antibody issue, genes encoding the nucleocapsid, membrane, and envelope protein of SARS-CoV were cloned and their expressions in mammalian cells were determined. After the intramuscular introduction into animals, we observed that the constructs of the E, M, and N genes could induce high levels of specific antibodies, T cell proliferations, IFN-gamma, DTH responses, and in vivo cytotoxic T cells activities specifically against SARS-CoV antigens. The highest immune responses were generated by the construct encoding the nucleocapsid protein. The results suggest that the N, M, and E genes could be used as the targets to prevent SARS-CoV infection in the DNA vaccine development.
Figures
Similar articles
-
Protein transfer enhances cellular immune responses to DNA vaccination against SARS-CoV.Viral Immunol. 2009 Dec;22(6):417-22. doi: 10.1089/vim.2009.0048. Viral Immunol. 2009. PMID: 19951178
-
Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.Microbiol Immunol. 2015 Aug;59(8):483-94. doi: 10.1111/1348-0421.12274. Microbiol Immunol. 2015. PMID: 26094825
-
Levamisole promotes murine bone marrow derived dendritic cell activation and drives Th1 immune response in vitro and in vivo.Int Immunopharmacol. 2016 Feb;31:57-65. doi: 10.1016/j.intimp.2015.12.015. Epub 2015 Dec 17. Int Immunopharmacol. 2016. PMID: 26706452
-
CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.Viruses. 2018 Dec 16;10(12):718. doi: 10.3390/v10120718. Viruses. 2018. PMID: 30558354 Free PMC article.
-
Ag85B of mycobacteria elicits effective CTL responses through activation of robust Th1 immunity as a novel adjuvant in DNA vaccine.J Immunol. 2005 Aug 15;175(4):2541-7. doi: 10.4049/jimmunol.175.4.2541. J Immunol. 2005. PMID: 16081827
Cited by
-
Evaluating the Impact of gRNA SNPs in CasRx Activity for Reducing Viral RNA in HCoV-OC43.Cells. 2022 Jun 7;11(12):1859. doi: 10.3390/cells11121859. Cells. 2022. PMID: 35740988 Free PMC article.
-
Immune responses to human respiratory coronaviruses infection in mouse models.Curr Opin Virol. 2022 Feb;52:102-111. doi: 10.1016/j.coviro.2021.11.015. Epub 2021 Dec 11. Curr Opin Virol. 2022. PMID: 34906757 Free PMC article. Review.
-
Single-Cell Analysis of Antigen-Specific CD8+ T-Cell Transcripts Reveals Profiles Specific to mRNA or Adjuvanted Protein Vaccines.Front Immunol. 2021 Oct 29;12:757151. doi: 10.3389/fimmu.2021.757151. eCollection 2021. Front Immunol. 2021. PMID: 34777370 Free PMC article.
-
Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.J Virol. 2021 Feb 24;95(6):e02002-20. doi: 10.1128/JVI.02002-20. Print 2021 Feb 24. J Virol. 2021. PMID: 33443088 Free PMC article.
-
COVID-19: The Emerging Immunopathological Determinants for Recovery or Death.Front Microbiol. 2020 Dec 1;11:588409. doi: 10.3389/fmicb.2020.588409. eCollection 2020. Front Microbiol. 2020. PMID: 33335518 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous